文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

超越PaO2/FiO2比值:从生理学视角重新思考ARDS严重程度

Beyond the PaO2/FiO2 ratio: Rethinking ARDS severity through the Lens of physiology.
PubMed 文献 · Ann Intensive Care · 2026-03-25
一句话结论叙述性综述指出PaO2/FiO2比值受呼吸机设置影响大且仅为静态指标,不应单独用于ARDS严重程度判断,建议结合PEEP调整指数、氧合指数、ROX指数及动态多维指标综合评估。

该叙述性综述重新审视PaO2/FiO2比值作为ARDS定义、严重程度分类和临床决策基石的生理学假设。文章指出该比值对呼吸机设置尤其PEEP高度敏感、在高吸入氧浓度下呈非线性行为、仅提供静态气体交换评估,无法反映肺可复张性、机械异质性和损伤时间演变。综述汇总了PEEP调整指数、氧合指数和ROX指数(SpO2/FiO2经呼吸频率调整)等替代与补充氧合指标的生理学依据、临床可解释性和床旁实用局限,并探讨将纵向氧合轨迹、呼吸力学、影像学肺充气评估和生物标志物亚表型整合为动态多维ARDS严重程度构念的新范式。

要点

  • PaO2/FiO2比值对呼吸机设置尤其PEEP高度敏感,不应单独解读为疾病严重程度标志。
  • PaO2/FiO2比值在高吸入氧浓度下呈非线性行为,仅提供静态气体交换评估,无法捕捉肺可复张性、机械异质性和损伤时间演变。
  • PEEP调整指数、氧合指数和ROX指数(SpO2/FiO2经呼吸频率调整)被综述作为补充工具讨论,并非替代PaO2/FiO2比值。
  • ARDS严重程度可概念化为动态多维构念,整合纵向氧合轨迹、呼吸力学、影像学肺充气评估和生物标志物亚表型。

研究设计与关键结果

  • 叙述性综述重新审视PaO2/FiO2比值的生理学假设,并评估其在当前ARDS实践中的作用。
  • 综述指出PaO2/FiO2比值对呼吸机设置尤其PEEP高度敏感,在高吸入氧浓度下呈非线性行为,仅提供静态气体交换评估。
  • 综述汇总支持PEEP调整指数、氧合指数和ROX指数(SpO2/FiO2经呼吸频率调整)等替代与补充氧合指标的证据,强调其生理学依据、临床可解释性和床旁实用局限。
  • 综述探讨将ARDS严重程度概念化为动态多维构念,整合纵向氧合轨迹、呼吸力学、影像学肺充气评估和生物标志物亚表型。

证据类型、等级与局限

  • 证据类型:叙述性综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 综述强调PaO2/FiO2比值不应被解读为疾病严重程度的单独标志,床旁解读氧合时需考虑呼吸机设置尤其PEEP的影响。
  • 综述将PEEP调整指数、氧合指数和ROX指数(SpO2/FiO2经呼吸频率调整)作为可能细化低氧血症情境解读的工具讨论,并非作为PaO2/FiO2比值的替代。
  • 综述提出将PaO2/FiO2比值重新置于整合生理学和生物学框架中,可能改善患者分层并使治疗决策更连贯。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Acute Respiratory Distress Syndrome (ARDS) is a heterogeneous clinical syndrome encompassing distinct physiological and biological patterns of lung injury. Despite this heterogeneity, the ratio of arterial oxygen partial pressure to inspired oxygen fraction (PaO2/FiO2) remains the cornerstone of ARDS definitions, severity classification, and clinical decision-making. While its simplicity has facilitated widespread use, the PaO2/FiO2 ratio incompletely reflects the underlying physiological mechanisms of hypoxemia and should not be interpreted as a stand-alone marker of disease severity. The PaO2/FiO2 ratio is highly sensitive to ventilator settings, particularly positive end-expiratory pressure (PEEP), exhibits nonlinear behavior at high inspired oxygen fractions, and provides only a static assessment of gas-exchange. Consequently, it fails to capture key dimensions of ARDS pathophysiology, including lung recruitability, mechanical heterogeneity, and the temporal evolution of injury and response to therapy. These limitations are increasingly relevant in contemporary intensive care, where ventilatory strategies and adjunctive therapies actively modify oxygenation independent of structural lung injury. In this narrative review, we critically re-examine the physiological assumptions underlying the PaO2/FiO2 ratio and evaluate its role in current ARDS practice. We synthesize evidence supporting alternative and complementary oxygenation metrics, such as PEEP-adjusted indices, the oxygenation index, and composite measures including the ROX index (SpO2/FiO2 adjusted for respiratory rate), emphasizing their physiological rationale, clinical interpretability, and practical limitations at the bedside. These metrics are discussed not as replacements, but as tools that may refine the contextual interpretation of hypoxemia. Beyond static oxygenation measures, we explore emerging paradigms that conceptualize ARDS severity as a dynamic, multidimensional construct, integrating longitudinal oxygenation trajectories with respiratory mechanics, imaging-based assessment of lung aeration, and biomarker-informed biological subphenotypes. Repositioning the PaO2/FiO2 ratio within this integrated physiological and biological framework may improve patient stratification, enhance the coherence of therapeutic decision-making, in line with the translational goals of modern intensive care.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Al-Husinat L, Khamis R, Azzam S, et al. Beyond the PaO2/FiO2 ratio: Rethinking ARDS severity through the Lens of physiology. Ann Intensive Care. 2026. PMID: 41938904. doi:10.1016/j.aicoj.2026.100057

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。